Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$79.67 - $173.23 $15,934 - $34,646
-200 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$78.5 - $100.64 $15,700 - $20,128
200 New
200 $20,000
Q2 2020

Aug 14, 2020

SELL
$38.5 - $76.05 $7,700 - $15,210
-200 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$40.99 - $52.56 $8,198 - $10,512
200 New
200 $8,000
Q2 2019

Aug 16, 2019

SELL
$35.45 - $48.2 $7,090 - $9,640
-200 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$28.02 - $40.87 $5,604 - $8,173
200 New
200 $0

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.05B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.